[HTML][HTML] DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases
Y Handelsman, JE Anderson, GL Bakris… - Metabolism, 2024 - Elsevier
The spectrum of cardiorenal and metabolic diseases comprises many disorders, including
obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular …
obesity, type 2 diabetes (T2D), chronic kidney disease (CKD), atherosclerotic cardiovascular …
Prevalence, cost, and burden of diabetic ketoacidosis
N Virdi, Y Poon, R Abaniel… - Diabetes Technology & …, 2023 - liebertpub.com
Diabetic ketoacidosis (DKA) is a life-threatening complication, which is most common in
individuals with type 1 diabetes (T1D) and is a significant risk for morbidity and mortality, and …
individuals with type 1 diabetes (T1D) and is a significant risk for morbidity and mortality, and …
Association between diabetes technology use and glycemic outcomes in adults with type 1 diabetes over a decade
OBJECTIVE To evaluate change in mean clinic HbA1c from 2014 to 2021 with diabetes
technology use in adults with type 1 diabetes. RESEARCH DESIGN AND METHODS In this …
technology use in adults with type 1 diabetes. RESEARCH DESIGN AND METHODS In this …
Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: an evidence-based approach to policymaking
Numerous studies have demonstrated the clinical benefits of continuous glucose monitoring
(CGM) in individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D) who are treated …
(CGM) in individuals with type 1 diabetes (T1D) and type 2 diabetes (T2D) who are treated …
Personalized glycated hemoglobin in diabetes management: closing the gap with glucose management indicator
TC Dunn, Y Xu, RM Bergenstal, W Ogawa… - Diabetes Technology …, 2023 - liebertpub.com
Glycated hemoglobin (HbA1c) has played a central role in the management of diabetes
since the end of the landmark Diabetes Control and Complications Trial 30 years ago …
since the end of the landmark Diabetes Control and Complications Trial 30 years ago …
Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial
SC Boeder, RL Thomas, MJ Le Roux… - Diabetes …, 2024 - Am Diabetes Assoc
OBJECTIVE To examine the effects of insulin-adjunctive therapy with a sodium–glucose
cotransporter 2 (SGLT2) inhibitor and a glucagon receptor antagonist (GRA) on glycemia …
cotransporter 2 (SGLT2) inhibitor and a glucagon receptor antagonist (GRA) on glycemia …
Diabetes Management in Detention Facilities: A Statement of the American Diabetes Association
DL Lorber, NA ElSayed, RR Bannuru, V Shah… - Diabetes …, 2024 - Am Diabetes Assoc
This statement provides guidance for diabetes care in detention facilities. It focuses on areas
where the processes for delivery of care to people with diabetes in detention facilities may …
where the processes for delivery of care to people with diabetes in detention facilities may …
Clinically similar clusters of daily continuous glucose monitoring profiles: tracking the progression of glycemic control over time
B Kovatchev, B Lobo - Diabetes Technology & Therapeutics, 2023 - liebertpub.com
Background: The adoption of continuous glucose monitoring (CGM) results in vast amounts
of data, but their interpretation is still more art than exact science. The International …
of data, but their interpretation is still more art than exact science. The International …
Association between adherence, A1C improvement, and type of continuous glucose monitoring system in people with type 1 diabetes or type 2 diabetes treated with …
PM Nemlekar, KL Hannah, CR Green, GJ Norman - Diabetes Therapy, 2024 - Springer
Introduction Use of continuous glucose monitoring (CGM) systems by people with diabetes
is associated with improved glycemic outcomes, including lower glycated hemoglobin …
is associated with improved glycemic outcomes, including lower glycated hemoglobin …
Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian …
S Del Prato, F Giorgino, K Szafranski… - Diabetes, Obesity and …, 2024 - Wiley Online Library
Aims To assess the cost–utility of the FreeStyle Libre flash continuous glucose monitoring
(CGM) system from an Italian healthcare system perspective, when compared with self …
(CGM) system from an Italian healthcare system perspective, when compared with self …